Walber Pinto Vieira Selected Research

Walber Pinto Vieira Research Topics

6	Rheumatoid Arthritis 01/2017 - 03/2010
4	Psoriatic Arthritis 09/2012 - 04/2010
3	Tuberculosis (Tuberculoses) 01/2017 - 01/2011
3	Rheumatic Diseases (Rheumatism) 01/2017 - 09/2012
3	Ankylosing Spondylitis 05/2015 - 01/2011
3	Infections 09/2012 - 03/2010
1	Necrosis 05/2015
1	Meningitis 09/2012
1	Lymphadenopathy 09/2012
1	Discitis 09/2012
1	Chronic Disease (Chronic Diseases) 01/2011
1	Chemical and Drug Induced Liver Injury 05/2010
1	Arthritis (Polyarthritis) 05/2010
1	Latent Tuberculosis 05/2010
1	Anemia 05/2010
1	Amyloidosis 03/2010
1	Inflammation (Inflammations) 03/2010
1	Meningeal Tuberculosis (Tuberculous Meningitis) 10/2009

4	Infliximab (Remicade)FDA Link 01/2017 - 10/2009
3	Pharmaceutical PreparationsIBA 01/2017 - 05/2010
3	Abatacept (Orencia)FDA Link 01/2017 - 04/2010
2	Etanercept (Enbrel)FDA Link 01/2017 - 03/2010
2	Tuberculin (PPD)IBA 09/2012 - 01/2011
2	Isoniazid (Ftivazide)FDA LinkGeneric 09/2012 - 05/2010
1	Adalimumab (Humira)FDA Link 01/2017
1	Rituximab (Mabthera)FDA Link 01/2017
1	Tumor Necrosis Factor InhibitorsIBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	tocilizumab (atlizumab)FDA Link 01/2017
1	Antirheumatic Agents (DMARD)IBA 01/2017
1	Biological ProductsIBA 05/2015
1	RA X peptideIBA 01/2011
1	Proteins (Proteins, Gene)FDA Link 03/2010
1	Amyloid (Amyloid Fibrils)IBA 03/2010